Great Novel Therapeutics Biotech & Medicals develops drugs to treat advanced and refractory cancers. It develops drugs for epigenetic modulators, epiimmune modulators, tumor microenvironment modulators, and HDACs 1, 2, 3 protein degrading agents. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $1.10 | N/A |
Market Cap | $41.65M | N/A |
Shares Outstanding | 37.89M | N/A |
Employees | 15.00 | N/A |